Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00006219

Trial Description

start of 1:1-Block title

Title

Extension of the EUROBservational Research Programme Atrial Fibrillation General Registry (EORP AFIB registry) for Germany

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

AFNET-EORP registry Atrial Fibrillation Germany

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The research programme is a large, scientific patient registry conducted by the Competence Network AFNET association in coorperation with the German Society of Cardiology and the European Societey of Cardiology in Germany. This registry is conducted throughout Europe in a comparable manner to document the management of atrial filbrillation. The objective of the german patient registry is to collect and analyse medical data in Germany in hospitals and outpatient institutions. Information serves for implementation in guidelines to improve the management of patients with atrial fibrillation.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

The research programme is a large, scientific patient registry conducted by the Competence Network AFNET association in coorperation with the German Society of Cardiology and the European Societey of Cardiology in Germany. This registry is conducted throughout Europe in a comparable manner to document the management of atrial filbrillation. The objective of the german patient registry is to collect and analyse medical data in Germany in hospitals and outpatient institutions. Information serves for implementation in guidelines to improve the management of patients with atrial fibrillation.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00006219
  •   2014/07/23
  •   [---]*
  •   yes
  •   Approved
  •   2013-533-f-s, Ethik-Kommission der Ärztekammer Westfalen-Lippe und der med. Fakultät der Westfälischen Wilhelms-Universität Münster
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   I48.9 -  [generalization I48: Atrial fibrillation and flutter]
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   patient registry: collection of data concerning management of treatment in patients with artrial fibrillation in in- and outpatient manner
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   [---]*
  •   [---]*
  •   Uncontrolled/Single arm
  •   Health care system
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The aim of the registry is the improvement of the management of patients with atrial fibrillation

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

none

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • [---]*
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2014/05/14
  •   3500
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

- Patients will be officially enrolled in the study only if ECG diagnosis of AF has been made.
- The qualifying episode of AF should have occurred within one year before the date of baseline.
- AF is the primary or secondary diagnosis, i.e. the current admission / visit may be due to other reasons.
- Patients need not be in AF at the time of enrolment.
- Signed Patient Inform Consent
- Age <= 18 years

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Patients who are currently or are planned to be taking part in a cardiac clinical trial.
Please note that patients can participate concomitantly in other registries.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Die Register-Studie wird durchgeführt vom: Kompetenznetz Vorhofflimmern AFNET e.V.
    • Mendelstraße 11
    • 48149   Münster
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • - Deutsche Gesellschaft für Kadiologie- European Society of Cardiology
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Universitätsklinikum Großhadern Medizinische Klinik I
    • Mr.  Professor  Michael  Näbauer 
    • Marchioninistraße 15
    • 81377  München
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Bristol Myers Squibb GmbH & Co kGaA
    • Arnulfstr. 29
    • 80636  München
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
  • start of 1:1-Block address otherSupport
    • Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.
    • Oudenarder Str. 16
    • 13347  Berlin
    • Germany
    end of 1:1-Block address otherSupport
    start of 1:1-Block address contact otherSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   http://dzhk.de/
    end of 1:1-Block address contact otherSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2018/12/31
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.